HOLX Archives - Markets

Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Ziopharm Oncology (NASDAQ: ZIOP) and Haemonetics (NYSE: HAE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hologic (HOLX

Needham analyst Michael Matson assigned a Buy rating to Hologic (HOLX – Research Report) today and set a price target

In a report released today, Michael Matson from Needham assigned a Buy rating to Hologic (HOLX – Research Report), with

Jefferies analyst Raj Denhoy maintained a Buy rating on Hologic (HOLX – Research Report) on July 29 and set a

Raymond James analyst Jayson Bedford maintained a Buy rating on Hologic (HOLX – Research Report) on June 8. The company’s

After Leerink Partners and BTIG gave Hologic (NASDAQ: HOLX) a Buy rating last month, the company received another Buy, this

Needham analyst Michael Matson assigned a Buy rating to Hologic (HOLX – Research Report) today and set a price target

1 2 3 … 13 »